Our Portfolio

The Rockefeller University

Ana Pereira, MD | New York, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $50,000 Funding Amount
  • 8/1/15 — 5/31/18 Project Duration
  • Clinical Program
  • Synaptic Activity and Neurotransmitters Target
  • Clinical Phase 2 Therapeutic Stage
  • Closed Status

The Rockefeller University

Ana Pereira, MD | New York, United States

Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment (follow-on funding)

GET IN TOUCH